Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICs in living donor kidney transplant
NCT02560220Phase 1Completed
- Sponsor
- Heidelberg University
- Start
- Aug 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mitomycin c in kidney transplant rejection, sponsored by Heidelberg University. Primary endpoint: Frequency of adverse events at 30 days. Started Aug 2015; status: completed.
02
Drugs
mitomycin c
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02560220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560220.